Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure (CardiAMP Heart Failure Trial)

NCT02438306 is registered in ClinicalTrials.gov with BioCardia, Inc. as lead sponsor.

NCT NCT02438306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02438306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure (CardiAMP Heart Failure Trial)
Lead sponsor
BioCardia, Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2016
Completion date
June 30, 2025
Enrollment
125 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, systolic